The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 09, 2022

Filed:

May. 02, 2017
Applicants:

Inserm (Institut National DE LA Sante ET DE LA Recherche Medicale), Paris, FR;

Sorbonne Universite, Paris, FR;

Universite Paris Descartes, Paris, FR;

Assistance Publique-hopitaux DE Paris (Aphp), Paris, FR;

Inventors:

Selim Aractingi, Paris, FR;

Mathieu Catela, Paris, FR;

Dany Nassar, Paris, FR;

Zhe Wang, Paris, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/19 (2006.01); A61P 19/02 (2006.01); A61P 17/02 (2006.01); A61K 45/06 (2006.01); C07K 16/28 (2006.01); C12N 15/115 (2010.01); G01N 33/50 (2006.01); A61K 47/68 (2017.01); A61K 39/395 (2006.01); C07K 14/52 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/195 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61K 47/68 (2017.08); A61P 17/02 (2018.01); C07K 16/2866 (2013.01); C12N 15/115 (2013.01); G01N 33/502 (2013.01); A61K 2039/505 (2013.01); C07K 14/523 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/75 (2013.01); C12N 2310/16 (2013.01);
Abstract

The present invention relates to methods and pharmaceutical compositions for the treatment of tissue lesions. The inventors showed that CCR2 is expressed on FMCs, especially on a subpopulation of progenitor cells, that they call 'fetal myeloid progenitor cells' (FMPCs), and mediates the recruitment of these cells to maternal wound tissue. Moreover, the inventors reported that recruited FMCs/FMPCs improve maternal skin wound healing by organizing blood vessel endothelium and secreting pro-angiogenesis peptides, particularly chemokine CXCL1, to enhance angiogenesis in wound. In particular, the present invention relates to CCR2 agonists for use in the treatment of tissue lesions in a subject in need thereof.


Find Patent Forward Citations

Loading…